Connect with us

Hi, what are you looking for?

Investing

Five things to know about berberine, the supplement being compared to Ozempic

By now, most Americans have heard of Ozempic, Mounjaro and Wegovy, the Type 2 diabetes drugs that are also helping people lose weight — in some cases, significant amounts. 

But not everyone may qualify for the drugs through their insurance. And the medications can be expensive for those without insurance — in some cases around $1,000 a month. On top of that, because of their surging popularity, the drugs can sometimes be in short supply. 

See…

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Videos

Watch full video on YouTube

Videos

Watch full video on YouTube

News

This week’s Fed meeting is extraordinary, and it could shock investors in a way we haven’t seen since 2008. So, I’m doing the weekly...

News

This article was written by Follow Leo Nelissen is an analyst focusing on major economic developments related to supply chains, infrastructure, and commodities. He...